Skip to main content
Watch Insiders
Market intelligence
ESPRHealthcare

Esperion Therapeutics Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Benjamin LookerChief Legal OfficerSale11,824$3.16$37,305
Jun 17, 2026Sheldon L. KoenigPresident and CEOSale53,588$3.16$169,070
Jun 17, 2026Benjamin HalladayChief Financial OfficerSale10,773$3.16$33,989